All One Health Content – Page 14
-
NewsNovel insights into Candida glabrata in pregnant women’s reproductive tracts in Hainan
A study of Candida glabrata in pregnant women with vaginal discomfort at Haikou Maternal and Child Health Hospital found that 64.5% of the 594 yeast isolates (383 isolates) showed resistance (R) or intermediate (I) phenotypes to at least one of four commonly used antifungals.
-
NewsFewer than half of parents think they have accurate information about bird flu
Most parents say they don’t know if there have been cases of bird flu in their state, and less than half feel that they are able to find accurate and current information about it, according to a new national US poll.
-
NewsNew study links sleep debt and night shifts to increased infection risk among nurses
A new study examining the effects of sleep patterns and shift work on the immune system has found that sleep debt and night shifts increase the risk of several common infections in nurses.
-
NewsBacterial ‘jumping genes’ can target and control chromosome ends
Researchers have discovered a new mechanism that transposons, or “jumping genes” use to survive and propagate in bacteria with linear DNA, with applications in biotechnology and drug development.
-
NewsTB vaccine candidate provides ‘elite’ protection
A tuberculosis vaccine candidate under development shows complete protection and superior immune response in nonhuman primates compared to the existing BCG vaccine.
-
NewsA 'Trojan Horse' approach to develop new antimalarial drugs
Researchers have discovered a key process whereby malarial parasites take up a human blood cell enzyme, which could provide a new approach for antimalarial treatment.
-
NewsDamaged but not defeated: Bacteria use nano-spearguns to retaliate against attacks
Scientists used state-of-the-art microscopy technology to mimic a nano-speargun, the type VII secretion system, used as a bacterial pinpoint counterattack tactic in response to cell envelope damage against rival bacteria.
-
NewsResearch identifies key antibodies for development of broadly protective norovirus vaccine
A new study identifies powerful antibodies capable of neutralizing a wide range of norovirus strains. The finding could lead to the design of broadly effective norovirus vaccine, as well as the development of new therapeutic antibodies.
-
NewsThroat microbiome holds clues to older Australians’ health
A simple swab from the back of the throat, known as the oropharynx, may offer clues about health challenges faced by aged care residents.
-
NewsInsilico Medicine deploys the first bipedal humanoid AI scientist in fully-robotic drug discovery laboratory
Insilico Medicine, a clinical-stage biotechnology company pioneering generative AI for drug discovery and development, has announced the deployment of the first bipedal humanoid in its AI-powered fully-robotic drug discovery laboratory.
-
NewsBAADesign enables the immune escaped etesevimab fully-armed against SARS-CoV-2 Omicron subvariants
BAADesign offers a powerful tool for reengineering monoclonal antibodies to combat emerging SARS-CoV-2 variants, providing a scalable solution for future pandemic preparedness, according to a new study.
-
NewsNew antibodies show potential to defeat all SARS-CoV-2 variants
Researchers discovered that a paired combination of antibodies binding to the two domains of the SARS-CoV-2 viral particle showed promising results in elimination of all virus variants caused in the COVID-19 pandemic.
-
NewsLonger breastfeeding linked to blood-pressure lowering effects of certain infant gut bacteria
An observational study has found that infants who had more diverse bacteria in their gut had lower childhood blood pressure, and this protective association was stronger if they were breastfed for at least six months.
-
NewsScottish biotech company Lentitek secures £1m funding to advance next generation cancer treatments
Biotech company Lentitek Ltd has secured £700,000 in private funding from Equity Gap, bringing its total investment to £1 million in the last six months. It develops manufacturing technologies for lentiviral vectors, used with CAR-T cell and gene therapies.
-
NewsWhite blood cells use brute force to dislodge bacteria
A $2.3 million grant from the National Institutes of Health (NIH).will support research into blood platelets and macrophages; how integrin tension influences cell function; and how this force affects platelet behavior.
-
NewsAMI member Christopher Stewart named as laureate in 2025 UK Blavatnik Awards for Young Scientists
Applied Microbiology International member Professor Christopher Stewart of Newcastle University has been named as one of three 2025 laureates in the eighth Blavatnik Awards for Young Scientists in the UK.
-
NewsHidden dangers and myths: What you need to know about HPV and cancer
While the human papillomavirus (HPV) is most associated with cervical cancer risk and women, a new survey commissioned by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) shows that the majority of people are unaware that ...
-
NewsResearchers develop innovative tool for rapid pathogen detection
A powerful pipeline was developed for more efficient and accurate primer design in qPCR that accelerates the diagnostic tests for infectious diseases and facilitates researches in rapidly evolving pathogens.
-
NewsNew biosensor can detect airborne bird flu in under 5 minutes
A new biosensor for monitoring aerosol particles of H5N1 works within five minutes, preserving the sample of the microbes for further analysis and providing a range of the pathogen concentration levels detected on a farm.
-
NewsCentauri Therapeutics selects first clinical candidate for immunotherapeutic treatment of Gram-negative bacterial infections
Centauri Therapeutics Limited has announced the selection of its first clinical candidate in the ABX-01 programme. The compound is designed to target serious Gram-negative bacterial infections in the lung.